Monogram Orthopaedics (NASDAQ:MGRM) Trading 2.9% Higher - What's Next?

Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Get Free Report) traded up 2.9% during mid-day trading on Wednesday . The stock traded as high as $2.54 and last traded at $2.49. 56,315 shares changed hands during mid-day trading, an increase of 32% from the average session volume of 42,710 shares. The stock had previously closed at $2.42.

Analysts Set New Price Targets

Several analysts have recently issued reports on the stock. Roth Capital raised shares of Monogram Orthopaedics to a "strong-buy" rating in a research report on Monday, December 9th. Roth Mkm assumed coverage on shares of Monogram Orthopaedics in a research report on Monday, December 9th. They issued a "buy" rating and a $4.00 price target on the stock.

Monogram Orthopaedics Trading Down 3.7 %

The stock's fifty day moving average is $2.62 and its two-hundred day moving average is $2.55. The firm has a market cap of $79.60 million, a P/E ratio of -4.94 and a beta of 1.55.

Institutional Trading of Monogram Orthopaedics

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Geode Capital Management LLC increased its holdings in Monogram Orthopaedics by 7.7% during the 4th quarter. Geode Capital Management LLC now owns 226,378 shares of the company's stock worth $537,000 after acquiring an additional 16,234 shares during the period. Northern Trust Corp grew its stake in Monogram Orthopaedics by 110.6% in the 4th quarter. Northern Trust Corp now owns 45,873 shares of the company's stock worth $109,000 after buying an additional 24,088 shares in the last quarter. Commonwealth Equity Services LLC grew its stake in Monogram Orthopaedics by 21.5% in the 4th quarter. Commonwealth Equity Services LLC now owns 41,628 shares of the company's stock worth $99,000 after buying an additional 7,366 shares in the last quarter. Fiduciary Family Office LLC purchased a new position in Monogram Orthopaedics in the 4th quarter worth approximately $70,000. Finally, State Street Corp purchased a new position in Monogram Orthopaedics in the 3rd quarter worth approximately $62,000. Institutional investors own 0.45% of the company's stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.